Application no. and date | 01991315.1 (espacenet) (Federated) (European Patent Register), 20011217 | Patent/reg. no. and date | DK/EP 1347987, 20041013 | Publication date | 20031001 | Priority no. and date | US 256875 P, 20001220 | EP pub. no. and date |
EP 1347987 20031001 | Effective date | | Applicant/owner | Merck Sharp & Dohme LLC, 126 East Lincoln Avenue Rayway, New Jersey 07065, US | Applicant ref. no. | 79707 | Inventor | Ghosal, Anima, 5505 Hana Road
Edison, NJ 08817, US, ZBAIDA, Shmuel, 22 Livingston Court
East Brunswick, NJ 08816, US, CHOWDHURY, Swapan, K., 7 Sunny Slope Drive
Warren, NJ 07059, US, IANNUCCI, Robert, M., 54 Wells Avenue
Hampton, NJ 08827, US, FENG, Wenqing, 420 River Road,
Apt. B2
Chatham, NJ 07928, US, ALTON, Kevin, B., 70 Summit Avenue
Cedar Knolls, NJ 07927, US, PATRICK, James, E., 104 Blawenburg Road
Belle Mead, NJ 08502, US, DAVIS, Harry, R., 64 River Bend Road
Berkeley Heights, NJ 07922, US | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | A61K 31/70, C07H 15/26 | Title | Sukkersubstituerede 2-azetidinoner, der er anvendelige som hypocholesterolæmiske midler | Int. application no. | US2001049127 | Int. publication no. | WO2002050090 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|